Express registration and login! If you have a Facebook or LinkedIN account, use one of the buttons on the left to either login or create a new account.
WASHINGTON, DC USA (UroToday.com) - May 16, 2011 - Clinicians treating bladder and prostate cancers face significant challenges not only in treating, but also diagnosing these diseases.
WASHINGTON, DC USA (UroToday.com) - May 16, 2011 - Employing a variety of the most sophisticated experimental techniques and procedures, researchers have advanced treatments for children in need of bladder reconstruction.
WASHINGTON, DC USA (UroToday.com) - May 16, 2011 - Men who smoke are more likely to have adverse pathology findings and a higher risk that PSA levels will elevate following radical prostatectomy for prostate cancer,
WASHINGTON, DC USA (UroToday.com) - May 16, 2011 - Abiraterone acetate (AA) with low-dose prednisone (P) extended overall survival with favorable PSA and radiographic responses in patients with castration-resistant prostate cancer progressing after docetaxel-based chemotherapy, according to updated data from COU-AA-301, a multi-institutional, randomized, double-blind, placebo-controlled, phase III study from researchers at 147 institutions across 13 countries.